DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY

被引：124
|
作者：
OVERWEG, J
BINNIE, CD
MEIJER, JWA
MEINARDI, H
NUIJTEN, STM
SCHMALTZ, S
WAUQUIER, A
机构：
[1] JANSSEN PHARMACEUT,B-2340 BEERSE,BELGIUM
[2] EPILEPSY CTR,DETROIT,MI
来源：
EPILEPSIA | 1984年 / 25卷 / 02期
关键词：
D O I：
10.1111/j.1528-1157.1984.tb04178.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：217 / 222
页数：6
相关论文
共 50 条
  • [1] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN REFRACTORY CHILDHOOD EPILEPSY
    BATTAGLIA, A
    FERRARI, AR
    GUERRINI, R
    BRAIN & DEVELOPMENT, 1991, 13 (04): : 217 - 222
  • [2] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN THERAPY-RESISTANT EPILEPTIC CHILDREN
    FICHSEL, H
    EPILEPSIA, 1988, 29 (03) : 342 - 342
  • [3] Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial epilepsy.
    Hsiang-Yu, Y
    Der-Jen, Y
    Chun-Hing, Y
    Ming-Shung, S
    EPILEPSIA, 1999, 40 : 97 - 97
  • [4] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED ADD-ON TRIAL OF LAMOTRIGINE IN PATIENTS WITH SEVERE EPILEPSY
    SANDER, JWAS
    PATSALOS, PN
    OXLEY, JR
    HAMILTON, MJ
    YUEN, WC
    EPILEPSY RESEARCH, 1990, 6 (03) : 221 - 226
  • [5] ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY
    ZAGNONI, PG
    BIANCHI, A
    ZOLO, P
    CANGER, R
    CORNAGGIA, C
    DALESSANDRO, P
    DEMARCO, P
    PISANI, F
    GIANELLI, M
    VERZE, L
    VIANI, F
    ZACCARA, G
    EPILEPSIA, 1994, 35 (01) : 107 - 112
  • [6] Double-blind, placebo-controlled, cross-over trial of allopurinol as add-on therapy in childhood refractory epilepsy
    Coppola, G
    Pascotto, A
    BRAIN & DEVELOPMENT, 1996, 18 (01): : 50 - 52
  • [7] Ramosetron as an add-on therapy for refractory fibromyalgia: a randomized, double-blind, placebo-controlled trial
    Park, Dong-Jin
    Jeong, Hyemin
    Choi, Sung-Eun
    Kang, Ji-Hyoun
    Lee, Jung-Kil
    Lee, Shin-Seok
    RHEUMATOLOGY, 2024, 63 (09) : 2372 - 2378
  • [8] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 400 MG/DAY TOPIRAMATE AS ADD-ON THERAPY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY
    MARTINEZLAGE, J
    BENMENACHEM, E
    SHORVON, SD
    WEBER, M
    EPILEPSIA, 1995, 36 : S149 - S150
  • [9] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 600 MG/DAY TOPIRAMATE AS ADD-ON THERAPY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY
    TASSINARI, C
    CHAUVEL, P
    CHODKIEWICZ, J
    SHORVON, SD
    HENRIKSEN, O
    DAM, M
    REYNOLDS, EH
    EPILEPSIA, 1995, 36 : S150 - S150
  • [10] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 800 MG/DAY TOPIRAMATE AS ADD-ON THERAPY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY
    BENMENACHEM, E
    DAM, M
    HENRIKSEN, O
    SCHMIDT, D
    EPILEPSIA, 1995, 36 : S150 - S150
12345